
EVOFEM BIOSCIENCE INC by Evofem Biosciences rose 59074.3% from $0.01 to a 1-year high of $6.45, ahead of the S&P 500's +4.7%. Its worst day was Apr 30 (−24.4%), and its low came Nov 10 at $0.01.
Nov 21, 2025 – Nov 17, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $0.00 was reported on $9.6M revenue.
+5.7% · S&P 500 −1.5%
EPS of $-0.04 was reported on $899,000.00 revenue.
−3.0% · S&P 500 −0.1%
Story events cover the past 12 months · Times ET
EVOFEM BIOSCIENCE INC by Evofem Biosciences closed at its lowest level of the year, 46.8% below where the year started.
−10.1% · S&P 500 −0.4%
Where it ended: a 1-year high close of $6.45 on Nov 17, 2026.
Nothing in the past 12 months.
All EVFM analyst actionsNothing in the past 12 months.
All EVFM dividend history